Submitted by Anonymous (not verified) on 21 July 2025 - 15:14
Guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD) - Revision 2
Source: